BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
LOCATION:Raum: Poster Area
DESCRIPTION:
DTSTART:20260618T073500Z
DTEND:20260618T074000Z
SUMMARY:Vortrag: DOC 2026 - EPO 6.4 Clinical improvements at Week 36 sustained to Week 64 with aflibercept 8 mg in macular edema following retinal vein occlusion\, with significantly fewer injections compared to aflibercept 2 mg: Results from the QUASAR trial
DTSTAMP:20260905T180434Z
UID:6a9c59b27ea52
END:VEVENT
END:VCALENDAR